Phesgo (Pertuzumab, trastuzumab, and hyaluronidase-zzxf)
Overview Phesgo is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) for use with chemotherapy to treat adults with early-stage HER-2 positive breast cancer. Phesgo is also approved… read more